瓣膜手术中预防性左心耳封堵:OPINION随机对照试验
OPINION多中心开放标签随机对照试验纳入无术前房颤但CHA₂DS₂-VASc≥2的瓣膜手术患者2118例,比较预防性外科左心耳封堵与不封堵。
要点
- 无术前房颤但CHA₂DS₂-VASc≥2的瓣膜手术患者,预防性左心耳封堵未显著降低1年血栓栓塞事件。
- 该结论基于意向性治疗人群,不支持下述患者常规预防性封堵。
核心结论
- 对于无术前房颤但CHA₂DS₂-VASc≥2的瓣膜手术患者,常规预防性左心耳封堵未显著降低1年缺血性卒中、TIA和心血管死亡的复合终点。
研究设计与样本
- OPINION为多中心、开放标签、优效性随机对照试验,在中国三个心脏外科中心开展。
- 纳入无术前房颤、CHA₂DS₂-VASc≥2且因二尖瓣或主动脉瓣病变需瓣膜修复或置换的患者,1:1随机分入外科左心耳封堵组或不封堵组。
- 共2157例患者入组随机,排除39例撤回知情同意后,意向性治疗人群2118例(封堵组1062例,对照组1056例)。
临床怎么用
- 对于无术前房颤但CHA₂DS₂-VASc≥2的瓣膜手术患者,不推荐常规行预防性外科左心耳封堵以降低1年血栓栓塞事件。
- 临床决策需结合患者术后房颤风险个体化评估,本试验结果不支持一刀切的预防性封堵策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: While surgical left atrial appendage occlusion (SLAAO) reduces stroke in atrial fibrillation (AF) patients, its efficacy in patients without pre-operative AF but with CHA₂DS₂-VASc ≥2 remains uncertain despite their high post-operative AF risk (15-54%). The aim of this study was to evaluate whether prophylactic SLAAO reduces post-operative thrombo-embolic events in valvular surgery patients. METHODS: The OPINION was a multicentre, open-label, randomized, superiority trial conducted at three cardiac surgery centres in China. Eligible non-AF patients with CHA₂DS₂-VASc ≥2 and an indication for valve repair or replacement due to mitral or aortic valve lesions were randomly assigned (1:1) to undergo SLAAO (intervention arm) or not undergo SLAAO (control arm) during surgery. The primary outcome was a composite of ischaemic stroke, transient ischaemic attack (TIA), or cardiovascular mortality assessed at 1 year. The primary analysis was done in the intention-to-treat population. RESULTS: Between April 2021 and June 2024, a total of 2157 patients were enrolled and randomized. After exclusion of 39 patients who withdrew informed consent, 2118 participants were included in the intention-to-treat population (1062 in the SLAAO group and 1056 in the control group). Baseline characteristics were well-balanced between the SLAAO group and control group (mean age 55.5 [11.4] vs 55.6 [11.5] years, P = .65; female 32.9% vs 32.3%, P = .78; CHA2DS2-VASc score 2.88 [0.98] vs 2.87 [0.96], P = .83; median EuroSCORE II 1.58% [1.42%] vs 1.56% [1.28%], P = .74). The 1-year primary endpoint occurred in 73 (6.9%) patients in the SLAAO group and in 87 (8.2%) patients in the control group (hazard ratio 0.83; 95% confidence interval 0.61-1.14; P = .25). CONCLUSIONS: For valvular surgery patients with CHA₂DS₂-VASc scores ≥2 but no pre-operative AF, routine prophylactic left atrial appendage closure did not significantly reduce the incidence of the primary composite endpoint (ischaemic stroke, TIA, and cardiovascular mortality) at 1-year follow-up. TRIAL REGISTRATION: ChiCTR.org registry ChiCTR2100042238.
引用
- Yuan, Ju, Wu, et al. Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial. Eur Heart J. 2026. PMID: 40888584. doi:10.1093/eurheartj/ehaf674
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。